Genetic Technologies Limited
ASX:GTG ISIN:AU000000GTG7
Genetic Technologies was an early pioneer in recognizing important new applications for "non-coding" DNA (DeoxyriboNucleic Acid). The Company has since been granted patents in 24 countries around the world, securing intellectual property rights for particular uses of non-coding DNA in genetic analysis and gene mapping across all genes in all multicellular species. Its three-pronged business strategy includes: 1) the global commercialization of its patents through an active licensing program; 2) the expansion of its dominant commercial genetic testing business in Australia; and, 3) the commercialization of its various research and development projects aimed at generating further intellectual property of global commercial significance.
View in Other Languages
News
Australian stocks ended flat on Wednesday as shares gave up early gains in the afternoon dragged by banks. Miners advanced as investors were optimistic about the iron ore prices. At the close, the benchmark S&P/ASX200 index was up 1.6 points at 4925.9 points, while the broader All Ordinaries index lifted 7.7 points, or 0.15 per cent, to 4947.2 points.
Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) wishes to advise of its progress in licensing its core intellectual property pertaining to non-coding DNA.
Genetic Technologies Limited (ASX: GTG) - Company Update - Mr Michael Ohanesian, CEO; Genetic Technologies Limited (ASX: GTG) present the following audio webcast regarding "Company Update". You may also download this audio webcast to your computer or portable audio player.
The August 2006 edition of our Health & Life Science Quarterly Blue Book profiles niche life sciences companies, with a focus on company strategies, key projects and significant milestones.
Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) is pleased to announce that it has entered into an agreement with DNA Bioservices Pty. Ltd. to provide paternity testing services to China.
GENETIC TECHNOLOGIES LIMITED Deciphering the Lingo - Biotechs Forum; (ASX: GTG) - Dr Mervyn Jacobson, CEO; Boardroomradio is pleased to announce that GENETIC TECHNOLOGIES LIMITED (ASX: GTG) has publis
###
48,618 COMPANY PROFILE VIEWS
- This Page Viewed: (Last 7 Days: 9) (Last 30 Days: 42) (Since Published: 8897)
